Close
Back to COGT Stock Lookup

Cogent Biosciences (COGT) – Hot FDA News

Dec 11, 2023 08:42 AM Cogent Biosciences (COGT) Declines 40% Following Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with AdvSM
Jun 10, 2022 09:20 AM Cogent Biosciences (COGT) Climbs 33% Following Positive Initial Clinical Data from Ongoing Phase 2 APEX Trial

Back to COGT Stock Lookup